Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 7th International Conference on Brain Injury and Neurological Disorders Amsterdam, Netherlands.

Day 2 :

Keynote Forum

Thomas F Feiner

Institute for EEG-Neurofeedback, Germany

Keynote: QEEG, sLORETA and neurofeedback in the diagnosis and treatment of emotional and cognitive disorders

Time : 09:45-10:30

Conference Series Brain Injury 2018 International Conference Keynote Speaker Thomas F Feiner photo
Biography:

Thomas F Feiner has more than 25 years’ experience as Occupational Therapist and Neuro-therapist. He conducted and participated in clinical research on QEEG and evoked potentials and Neurofeedback since 2006. He developed computer software for testing the auditory order threshold on regular Windows PCs and created an easy to use stimulus presentation program for research in the field of evoked potentials and other psychophysiological measures. He is the Clinical Director of the Center for Neurofeedback in Munich and established the Institute for EEG-Neurofeedback in 2008 which offers professional education programs in the field of Neurofeedback, Quantitative EEG and evoked potentials. Since 2017, he conducted research on the EEG of meditators in great study of more than 1000 subjects. He is Founder and Owner of Neurofeedback-Partner GmbH. His focus is on research and development of integrated neurofeedback protocols, event related potentials in combination with low level brain stimulation technologies.

 

Abstract:

The Quantitative Electroencephalography (QEEG) is a technique of taking EEG data and producing a visual map of the type and location of rhythms in the brain. The QEEG provides an analysis of brainwave function. The readings are compared and cross-referenced to a normative database. This helps clinicians to determine if the brain is regulated or dysregulated. This simple process takes only about an hour but produces a huge amount of data that provides information on how the brain is functioning which only Quantitative EEG is capable of. By using a brain map, we can analyze the EEG in different ways. Most important is to look at dysregulation that can show with a wide range of varieties, clusters and patterns which can lead to symptoms associated with ADD/ADHD, Asperger’s Syndrome, Autism Spectrum Disorder, Depression, Anxiety and many other symptoms. This particular assessment of the brainwaves helps the clinician to apply neurofeedback exactly according to
his symptoms and complaints. With Neurofeedback, eventually the brainwave activity is “shaped” toward a more desirable, more regulated performance. To get the best outcome in the Neurofeedback treatment, it is important to target the specific locations in the brain by utilizing knowledge from neuroscience, neuroanatomy and learning theory (operant conditioning). The treatment
is specific to the conditions which are addressed, and specific to the individual. The results become real and lasting.

  • Brain Stroke| Spinal Cord Disorders | Psychiatric Disorders | Neuro inaging and Radiology| Brain Mapping
Location: Meeting Place 3
Speaker

Chair

Trevor Archer

University of Gothenburg, Sweden

Speaker

Co-Chair

Reza Amani

Isfahan University of Medical Sciences, Iran

Session Introduction

Lena Ehrhard

Institute for EEG-Neurofeedback Munich, Germany

Title: Q-EEG analysis as foundation for neurofeedback treatments on the neurologically disordered patients

Time : 10:30-11:00

Speaker
Biography:

Lena Ehrhard successfully completed her apprenticeship as Occupational Therapist at the Rhön-Akademie in Schwarzerden/Germany in 2002. She also finished her professional training on Psychic Trauma Therapy in 2012. As a co-partner of the health care center in Rotenburg an der Fulda/Germany, she is currently working as a Neurofeedback Therapist, using a 19-channel-discovery-system, trained by IFEN, Munich/Germany.

 

Abstract:

New techniques make writing Q-EEG possible, especially ambulant treatment for severe affected patients in hospitals or at home. On this foundation is a grounded and progressive neurofeedback therapy in nearly everywhere possible. Patients who couldn't take part in treatments due to mobility reasons can now do so. Case by case examples (locked-in, stroke, pain disorders) will demonstrate appraisal, methods and the betterment of the patient during the ambulant neurofeedback therapy

Speaker
Biography:

Adrián Gaitán Fariñas is a PsyD professional who conducts the first clinic specialized in QEEG and Neurofeedback treatment in the area of Cadiz (South of the Spain). He is a QEEG and Neurofeedback Instructor at the IFEN Institute, and European Institution devoted to train professionals in Neurofeedback therapy. He is also a QEEG and Neurofeedback Treatment-Planning Consultant of several clinics in Spain.

 

Abstract:

Neurofeedback is a form of neuromodulation that uses brainwave conditioning to modify aberrant neural functioning and optimize brain functioning, leading to emotional and cognitive improvements. It has also been proposed to provide benefits in brain insults like traumatic brain injuries and stroke; through training the damaged networks and facilitating cognitive remediation. A recent evolution of Neurofeedback known as sLORETA neurofeedback uses an inverse problem algorithm solution to identify and train activity of specific Brodmann areas instead of EEG activity detected at the scalp, and it is believed to provide faster and better outcomes than classic neurofeedback due to the superior precision. We will review the case of a patient suffering from alexia following a left hemisphere stroke. QEEG and sLORETA brain imaging showed dysregulation in Brodmann areas linked to reading, and neuropsychological examination revealed profound impairment in reading function. After a relatively short, combined treatment with cognitive stimulation and sLORETA z-score neurofeedback of the damaged networks, patient experimented a significant improvement in reading and cognitive functioning. QEEG and sLORETA imaging demonstrated enhanced regulation of electrical activity in the areas trained, suggesting that sLORETA neurofeedback helped to recover the function impaired due to the brain damage. Implications of sLORETA neurofeedback in the cognitive remedation and brain insult treatment will be discussed

Hashim Hasan Balubaid

King Saud Bin Abdulazizz University for Health Sciences, KSA

Title: Quality of life post stroke

Time : 11:45- 12:15

Speaker
Biography:

Hashim Hasan Balubald has been graduated from the Medical College at King Abdulaziz University-Jeddah in 1995 and completed his Internship at King Abdulaziz University- Hospital from 1995 to 1996 to 2001. He has joined the residency program in Internal Medicine at King Fahad National Guard hospital in Riyadh, Saudi Arabia.

 

Abstract:

Stroke is a chronic disease that affects the functional, cognitive and psychosocial status of the patient. Post stroke, the patient needs extensive medical, physical and psychosocial interventions. Rehabilitation to get the patient back into the community is essential. Things that need to be addressed and assessed post stroke include the following: social reintegration, depression, cognition, sexuality and care giver burden.

 

Speaker
Biography:

Raed M Aljubour, MD, FEBNS, is a Consultant Neurosurgeon at KHMC, Jordan. He has completed his Fellowship in Skull Base from INI Hannover, Germany. He is a Member in European Board of Neurological Surgery, Arab Board of Health Specializations. He pursued his Diploma in EuroSPIN.

 

Abstract:

Objective: Severe brain injury is defined as a brain injury resulting in a loss of consciousness of greater than 6 hours and a Glasgow Coma Scale of 3 to 8. Patients in this condition need endotracheal intubation and mechanical ventilation, the main cause of secondary brain injury is increase in intracranial pressure which is preventable when it is detected and can decrease mortality and morbidity rate.

Method: This study focused in management of severe head injury and of intracranial pressure monitoring to decrease the morbidity and mortality, multi-centric study compares the outcome between patients with same GCS in hospital with intracranial pressure monitor versus patients in hospital without intracranial pressure monitor.

Results: We took 2 groups with same GCS, first group patients in hospital with intracranial pressure monitor and second group patients in hospitals without intracranial pressure monitor. Compare the mortality rate in both groups, with same GCS which shows less mortality and morbidity rate is more significant in GCS 7 and 8.

Conclusion: Hospital with intracranial pressure monitor especially intra-ventricular had less mortality and morbidity rates in patients with severe head injury with GCS 7 and 8, no difference in GCS below 6.

 

Reza Amani

Isfahan University of Medical Sciences, Iran

Title: Vitamin D levels and body antioxidant status in ischemic stroke patients: A case-control study

Time : 13:35-14:05

Speaker
Biography:

Reza Amani is the academic member at Isfahan University of Medical Sciences (IUMS), Isfahan, Iran. He received his PhD and MSc in Nutrition Science from Tabriz University of Medical Sciences, Tabriz, Iran. He has obtained his fellowship in Clinical Nutrition. He has also worked at the University of Sydney, Australia as Visiting Scholar. He has published more than 120 scientific papers in Persian and English academic journals and has supervised above 50 Post-graduate theses and research projects. Currently, he is working as the Head of Food Security Research Center at IUMS. He has been awarded as eminent Researcher at Ahvaz Jundishapur University of Medical Sciences for five years.

 

Abstract:

Background & Aim: Stroke is the second cause of death among elderly people and oxidative stress plays important role in brain damage after stroke. The aim of this study was to evaluate the status of Vitamin D, antioxidant enzymes, and the relation between the ischemic stroke patients.

Materials & Methods: This case–control study was carried out on 36 patients with ischemic stroke patients and 36 matched subjects as controls. Intake of fruits and vegetables, exposure of sunlight, serum lipid profile, concentrations of serum Vitamin D, activities of serum superoxide dismutase, and glutathione peroxidase enzymes were determined.

 

Results: Severe Vitamin D deficiency was seen in 30% of the patients versus 11% of the controls (P<0.05). Consumption of fruits and vegetables was lower in patients than that of controls (P<0.05). Activities of antioxidant enzymes and intake of fruits were positively correlated in stroke patients (P=0.02). The most potent predictors of stroke risk were hypertension, high levels of low-density lipoprotein cholesterol (LDL-C) and history of cardiovascular disease (CVD) (odds ratios: 3.33, 3.15, and 3.14, respectively, P<0.05 for all). There was no association between 25(OH) D levels with activities of serum antioxidant enzymes and lipid profile in the two groups.

Conclusion: Ischemic stroke patients have higher prevalence of severe Vitamin D deficiency and lower intakes of fruits and vegetables. Intake of fruits was positive correlated to higher antioxidant enzyme levels. High levels of blood pressure, history of CVD, and high LDL‑C levels are the strongest predictors of ischemic stroke.

 

Speaker
Biography:

Anatoly Uzdensky has completed his PhD in 1980 from Rostov State University (Russia). He is the Principal Investigator and Head of the Laboratory of Molecular Neurobiology in the Sothern Federal University (Rostov-on-Don, Russia). He has published more than 120 papers in reputed journals.

 

Abstract:

In focal ischemic stroke, vessel occlusion rapidly induces local infarct of the brain tissue. During next hours, injurious factors (glutamate, Ca2+ and others) propagate to surrounding tissue and form the transition zone, penumbra, where both, neurodegeneration and neuroprotection processes are developed. Cell protection in penumbra is the aim of neurologists, but effective neuroprotectors are not found yet. So, deeper studies of biochemical processes in penumbra are needed. Neuronal and signaling antibody microarrays (Panorama, Sigma-Aldrich) were used to study changes in expression of >400 signaling and neuronal proteins in penumbra surrounding photothrombotic infarct core in rat cerebral cortex 1, 4 or 24h after impact comparing with untreated contralateral cortex. The greatest changes were observed at 4h after photothrombosis. They included simultaneous upregulation of proteins involved in diverse subcellular systems: proapoptotic (caspases 3, 6 and 7, Bcl-10, AIF, SMAC/DIABLO, p53, E2F1, p38, JNK, NMDAR2a, c-myc, Par4, p75, GADD153, GAD65/67, PSR) and anti-apoptotic (Bcl-x, p63, p21WAF-1, MDM2, ERK5, MKP-1, NEDD8, estrogen receptor) proteins. Various signaling proteins (calmodulin, CaMKIIα, CaMKIV, ERK1/2, MAKAPK2, PKCα, PKCβ, PKCμ, RAF1, protein phosphatase 1α, ATF2, EGF receptor, DYRK1A) were upregulated, whereas others (phospholipase Cγ1, S-100, GSK-3, Axin1, NUMB, TDP-43, FRAT1) - downregulated. Proteins involved in mitochondria quality control (Pink1, parkin), proteolysis (ubiquilin-1, UCHL1), intercellular interactions (N-cadherin, PMP22), neurite integrity and guidance (Nav3, CRPM2, PKCβ2) were overexpressed. Proteins associated with actin cytoskeleton (cofilin, actopaxin, p120CTN, α-catenin, p35, myosin Va and pFAK) were upregulated, whereas other cytoskeleton components (ezrin, tropomyosin, spectrin (α+β), βIV-tubulin, polyglutamated β-tubulin, doublecortin, neurofilaments 68 and M, cytokeratins 7 and 19) - downregulated. Downregulation of syntaxin, synaptophysin, synaptotagmin, VILIP, ALS2, and adaptin β1/2 indicated impairment of vesicular transport and synaptic processes. Enzymes that mediate dopamine biosynthesis (tyrosine hydroxylase, DOPA decarboxylase, dopamine transporter) were downregulated, whereas proteins involved in biosynthesis of serotonin and GABA (tryptophan hydroxylase, MAO-B, glutamate decarboxylase) - upregulated. Down-regulation of CDK6, CDC7 kinase, TRF1, and topoisomerase-1 suppressed proliferation. Levels of mitochondrial antioxidant protein AOP-1, chaperons Hsp70 and Hsp90 were reduced. Amyloid precursor protein, nicastrin and β-amyloid were upregulated. These data provide the integral view on neurodegeneration or neuroprotection processes in penumbra after photothrombotic infarct. Some of these proteins can be considered as potential targets for anti-stroke therapy. Supported by Russian Science Foundation (14-15-00068) and Russian Ministry of Education and Science (6.4951.2017/6.7).

 

Anthony Lee

Harvard University, USA

Title: The spinal exam part 1: Lumbo-sacral
Speaker
Biography:

Anthony Lee has received his Bachelor of Science Degrees in Mechanical Engineering and in Biology with a minor on Music. He pursued his MD from The College of Physicians and Surgeons at Columbia University. He has completed his Internship at New York Hospital Queens and his residency training at NYU in Physical Medicine and Rehabilitation. He has obtained his Fellowship training at New England Baptist Hospital in Spine Medicine. He is a Faculty Physician at Harvard Medical School, directly responsible for training future pain physicians in one of the top pain fellowship programs in the United States. His expertise is in complex spinal disorders, headaches and general rehabilitation. He divides his clinical work between the Department of Anesthesia and the Department of Orthopedic Surgery at Beth Israel Deaconess Medical Center.

 

Abstract:

The lumbo-sacral spinal exam is a vital component of the patient, encounter when evaluating for back pain, leg pain, paresthesias, weakness, or change in gait. It should be performed in an optimal manner that is evidenced based with the patient strongly encouraged to fully participate in. It need not be superfluous or tedious if it is focused based on the patient history. I usually perform a complete exam on the initial visit and a focused exam on follow-up visits. This usually includes examination of the hips and lower extremities as well. This workshop will focus on patients with complaints related to the lumbo-sacral spine. It is important to keep in mind that no single data point from the history or from the physical, radiographic or electromyographic exam can definitively make a diagnosis. Multiple data points should be collected and a differential diagnosis should then be drawn from these data.